Everyone’s favorite troubled biotech giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is making the news cycles rumble once again with official talks that the firm’s …
Sangamo BioSciences, Inc. (NASDAQ:SGMO), a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire PLC (ADR) (NASDAQ:SHPG), have agreed …